SB-480848 In Subjects With Coronary Heart Disease

NCT00269048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

969

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: SB-480848
DRUG: placebo

Sponsor

GlaxoSmithKline